Oxitec

From Powerbase
Revision as of 16:48, 31 October 2013 by Matthew Pringle (talk | contribs) (basic page created)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search

Background

Oxitec is a British biotech company specialising in tackling dengue fever and damaging agricultural pests. Oxitec does basic research and creates product candidates at its laboratories in the UK. Optimised candidates are evaluated and tested in laboratory and field settings in conjunction with partners.[1]

People

Executive team

  • Hadyn Parry, Chief Executive Officer
  • Dr Luke Alphey, Chief Scientific Officer
  • Bill Fleming, Chief Financial Officer
  • Camilla Beech, Regulatory Affairs Manager
  • Glen Slade, Head of Business Development

Non-executive team

  • Dr Christopher Richards, Chairman
  • Dr David Buckeridge
  • Landon Clay
  • Edward Mott

Affiliations

Contact

Oxitec Ltd
71 Innovation Drive
Milton Park
Abingdon
UK, OX14 4RQ
t: +44 (0) 1235 832 393
f: +44 (0) 1235 861 138
e: info@oxitec.com

Notes

  1. Our pipeline, Oxitec website. Accessed on 31/10/2013.
  2. Data from Internet Archive holdings of the Science Media Centre website, 2002-2013.